Skip to main content

Increasing the use of long-acting reversible contraception: The Australian Contraceptive ChOice pRoject (ACCORd)

Project Member(s): Haas, M.

Funding or Partner Organisation: National Health & Medical Research Council (NHMRC Project Grants)

Start year: 2015

Summary: Evidence shows that the increased use of long-acting reversible contraceptives (LARCs), such as intrauterine devices and implants, has the potential to reduce unintended pregnancy and abortion rates. In 2013, Sexual Health and Family Planning Australia (SHFPA) released a national position statement, endorsed by the Public Health Association of Australia (PHAA) and the Royal Australian College of General Practitioners (RACGP), that put forward a framework for action to increase the use of LARCs in Australia. This framework included recommendations that health service providers discuss the benefits of LARCs with all women requiring contraception and that local referral pathways be developed for women of all ages to improve access to LARCs. The Australian Contraceptive CHOICE study (ACCORd) seeks to put these recommendations into practice by adapting the successful US Contraceptive CHOICE study to the Australian context and evaluating the outcomes.


Mazza, D, Watson, CJ, Taft, A, Lucke, J, Mcgeechan, K, Haas, M, Mcnamee, K, Peipert, JF & Black, KI 2020, 'Increasing long acting reversible contraceptives: The Australian Contraceptive ChOice pRoject (ACCORd) cluster randomized trial.', American Journal of Obstetrics and Gynecology.
View/Download from: Publisher's site

Lynch, M, De Abreu Lourenco, R, Flattery, M & Haas, M 2019, 'Reviewing the Cost-Effectiveness of Long Acting Reversible Contraceptive Methods in an Australian Context', Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 59, no. 1, pp. 21-35.
View/Download from: Publisher's site

Keywords: long acting contraception, contraceptive choices, Australia

FOR Codes: Health Economics, Public Health and Health Services not elsewhere classified, Health Policy Economic Outcomes, Health Policy Evaluation